Cormark Analysts Give Vitalhub (TSE:VHI) a C$7.50 Price Target

Cormark set a C$7.50 price objective on Vitalhub (TSE:VHI) in a research note issued to investors on Monday, BayStreet.CA reports. The brokerage currently has a buy rating on the stock. Cormark also issued estimates for Vitalhub’s FY2025 earnings at $0.26 EPS.

VHI has been the subject of a number of other research reports. Eight Capital lifted their price objective on shares of Vitalhub from C$5.00 to C$6.25 and gave the company a buy rating in a research report on Tuesday, February 6th. Canaccord Genuity Group lifted their price objective on shares of Vitalhub from C$5.25 to C$5.50 and gave the company a buy rating in a research report on Tuesday, February 6th.

Vitalhub Trading Up 3.9 %

Vitalhub stock opened at C$6.60 on Monday. The company has a market cap of C$288.49 million, a P/E ratio of 66.00, a price-to-earnings-growth ratio of 0.42 and a beta of 1.21. Vitalhub has a 1-year low of C$2.35 and a 1-year high of C$6.86. The company has a fifty day simple moving average of C$6.03 and a 200 day simple moving average of C$4.56.

Vitalhub (TSE:VHI) last released its earnings results on Thursday, March 21st. The company reported C$0.03 earnings per share for the quarter, missing analysts’ consensus estimates of C$0.04 by C($0.01). The business had revenue of C$13.60 million during the quarter, compared to the consensus estimate of C$13.68 million. Vitalhub had a net margin of 8.66% and a return on equity of 5.78%. On average, equities research analysts forecast that Vitalhub will post 0.1501823 EPS for the current year.

About Vitalhub

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.